Melbourne Clinical Hypnotherapy - Melbourne - Dr Bruce Alexander - Paul Brickhill

Dr Bruce Alexander has devoted his life to the improvement of physical and psychological health. He began his career as a medical research scientist, where he and coworkers were able to identify a crucial gene in the developement of leukaemia.

Most cancers are linked to or caused by lifestyle issues, for example smoking, eating, drinking, poor sleep or lack of exercise. Many cancers can be prevented by behavioural changes but unfortunately this is easier said than done. Hypnosis is an excellent technique for behavioural change as well as a useful tool to help resolve emotional and stress related issues.

In 1999 Bruce completed training in clinical hypnosis and psychotherapy at The Australian Academy of Hypnotic Science. Since that time he has helped thousands of private clients resolve a variety of physical and psychological health issues. He has applied his diverse range of research and clinical skills to the corporate sector by providing programs in stress resilience and smoking cessation.

Bruce also tutors Medical Students at Monash University and has lectured at The Australian Academy of Hypnotic Science.

Qualifications

Bachelor of Science, University of Melbourne, 1987
Doctor of Philosophy (Medicine), University of Melbourne, 1998
Diploma of Psychotherapy, Australian Academy of Hypnotic Science, 1997
Diploma of Health (Hypnosis), Australian Academy of Hypnotic Science, 1999
Certificate in Workplace Training (Category 1), 1999
Certificate IV in Assessment and Workplace Training, 2000
Full Member, Australian Society of Clinical Hypnotherapists

Previous Employment

The Ludwig Institute of Cancer Research, Australia
The University of Melbourne, Australia
The Institute of Molecular Pathology, Vienna
The Walter and Eliza Hall Institute, Australia
Monash University, Australia
The Australian Academy of Hypnotic Science

Research Publications

Phenotypic effect correlating with loss of a novel tumor suppressor gene: towards cloning by complementation.
Cook WD, Alexander BJ. Leukemia.
1998 Dec;12(12):1937-43.

Establishment of multipotential and antigen presenting cell lines derived from myeloid leukemias in GM-CSF transgenic mice.
Rasko JE, Metcalf D, Alexander B, Strasser A, Begley CG. Leukemia.
1997 May;11(5):732-42.

Gene deletion explains both in vivo and in vitro generated chromosome 2 aberrations associated with murine myeloid leukemia.
Alexander BJ, Rasko JE, Morahan G, Cook WD. Leukemia.
1995 Dec;9(12):2009-15.

Tumor-associated karyotypic lesions coselected with in vitro macrophage differentiation.
Alexander B, Berger R, Day LM, Hogarth PM, Feneziani A, Cook WD. Genes Chromosomes Cancer.
1992 Nov;5(4):286-98.